Bull NVAX - novavax 150 dollar targetI am looking for a 150 dollar target on Novavax but not invested in this since my bank (Handelsbanken) don't supply this.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.16 USD
−545.06 M USD
983.71 M USD
152.99 M
About Novavax, Inc.
Sector
Industry
CEO
John C.s Jacobs
Website
Headquarters
Gaithersburg
Founded
1987
FIGI
BBG000NVSBL7
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Novavax Set to Soar: A Bullish Breakout in Sight?Unveiling the Potential of NVAX
Novavax (NVAX), a notable biopharmaceutical stock, has witnessed a dramatic journey, plunging from its February 2021 high of approximately $330 to a critical low of $3.53 in February 2024. While this decline may appear daunting, our technical analysis suggests that i
$NVAX #nvax $24 target by 12/9/2024Novavax, NASDAQ:NVAX phase 3 trial begins on 12/9/2024. ctv.veeva.com A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine
$NVAX $24 Dec 9, 2024NASDAQ:NVAX Novavax stock, $24 on 12/9/24. ctv.veeva.com Phase 3 trial begins on Monday, Dec. 9, 2024. Squeezing.
Novavax Inc (Extended Hours) | Chart & Forecast SummaryKey Indicators On Trade Set Up In General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Notes On Session
# Novavax Inc (Extended Hours)
- Double Formation
* Retracement Template 50%| Short Set Up | Subdivision 1
* Wedge Structure | A+ Set Up | At Area 23.80 | Subdivision 2
- Triple Forma
NVAX will make us happy soon.1) RSI 2 moving averages will cross each other soon. Purple one 38.14 and Green one 38.69. If purple one cut above green one it will be buy sign. I am waiting for buying next year because this is monthly chart. I hope RSI's 2 moving averages will cross each other. 36.91, 35.21 and 31.72 were very im
NVAX, is prepping for a turnaround ERA. Massive Growth Prospect!NVAX surged an impressive 29.4% last trading day with significant volume. Net positive volume increased massively from 6.33M to 28.12M for a 344% increase. These extraordinary numbers should be telling of what's to come in the mid to long term.
Buyers are back in the scene, positioning at the curr
NVAX at the crossroadNVAX had some headwinds news with the small set back on the 2nd stage clinical trial. The 15% drop landed the NVAX at the bottom of the trend line, a confirmed break below low (below 10$ for 2+ trading days) would be a strong sell signal, or a potential rebounded to the up trendline with more suppor
Buy it!Novavax ...with the most recent collaboration with SNY Sanofi bolstering the stock price to $26.. I initiated a position at $12.66..
The cash on hand is 1.3B, Debt 2.5B..
I ll be buying all dips...hopefully down to $6/share... I initiated a position because of the FOMO factor.
NFA
The NVAX 2nd Wave Has Just Begun I will be following this one very closely. Today's price action is very alarming having jumped over 20% on the day as volume reached 17 M vs its 6M daily average.
I plan on capitalizing on the hype and volatility that this stock generates and will be sharing some thoughts on the lower time frames.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where NVAX is featured.
Frequently Asked Questions
The current price of NVAX is 8.70 USD — it has increased by 0.23% in the past 24 hours. Watch Novavax, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Novavax, Inc. stocks are traded under the ticker NVAX.
NVAX stock has fallen by −3.33% compared to the previous week, the month change is a 8.75% rise, over the last year Novavax, Inc. has showed a 74.35% increase.
We've gathered analysts' opinions on Novavax, Inc. future price: according to them, NVAX price has a max estimate of 25.00 USD and a min estimate of 9.00 USD. Watch NVAX chart and read a more detailed Novavax, Inc. stock forecast: see what analysts think of Novavax, Inc. and suggest that you do with its stocks.
NVAX reached its all-time high on Feb 9, 2021 with the price of 331.68 USD, and its all-time low was 3.53 USD and was reached on Feb 5, 2024. View more price dynamics on NVAX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NVAX stock is 6.19% volatile and has beta coefficient of 2.64. Track Novavax, Inc. stock price on the chart and check out the list of the most volatile stocks — is Novavax, Inc. there?
Today Novavax, Inc. has the market capitalization of 1.39 B, it has increased by 2.04% over the last week.
Yes, you can track Novavax, Inc. financials in yearly and quarterly reports right on TradingView.
Novavax, Inc. is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
NVAX earnings for the last quarter are −0.76 USD per share, whereas the estimation was −0.79 USD resulting in a 3.93% surprise. The estimated earnings for the next quarter are −0.60 USD per share. See more details about Novavax, Inc. earnings.
Novavax, Inc. revenue for the last quarter amounts to 84.51 M USD, despite the estimated figure of 73.78 M USD. In the next quarter, revenue is expected to reach 102.74 M USD.
NVAX net income for the last quarter is −121.30 M USD, while the quarter before that showed 162.38 M USD of net income which accounts for −174.70% change. Track more Novavax, Inc. financial stats to get the full picture.
No, NVAX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 1.54 K employees. See our rating of the largest employees — is Novavax, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Novavax, Inc. EBITDA is −243.18 M USD, and current EBITDA margin is −38.00%. See more stats in Novavax, Inc. financial statements.
Like other stocks, NVAX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Novavax, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Novavax, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Novavax, Inc. stock shows the sell signal. See more of Novavax, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.